OncoSec医疗
ONCS

股本结构

单位：万股
公告日期 2023-05-18 2023-04-11 2023-03-14 2023-03-14 2022-12-01 2022-12-01
证券总股本 596.26 455.42 297.12 297.12 297.05 180.38
普通股本 596.26 455.42 297.12 297.12 297.05 180.38
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2023-05-18 2023-04-11 2023-03-13 2023-01-31 2022-12-01 2022-11-22
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2023-05-18 596.26 未披露
更多>>
Common Stock offered 1,408,384 shares by the company
2023-05-18
2023-04-11 455.42 未披露
更多>>
Common Stock offered 1,582,932 shares by the company
2023-04-11
2023-03-14 297.12 未披露 定期报告 2023-03-13
2023-03-14 297.12 未披露
更多>>
From October 31, 2022 to January 31, 2023 Stock-based compensation expense December 2022 Public Offering, net of $680,181 issuance costs Exercise of pre-funded warrants Reverse split fractional shares Common stock issued for employee stock purchase plan
2023-01-31
2022-12-01 297.05 未披露
更多>>
Common Stock offered 1,166,667 shares by the company
2022-12-01
2022-12-01 180.38 未披露 定期报告 2022-11-22
2022-11-14 179.08 未披露
更多>>
OncoSec Medical Incorporated announced it intends to effect a 1-for-22 reverse split of its issued and outstanding common stock. The reverse stock split will become effective on November 9, 2022.
2022-11-09
2022-10-31 3939.63 未披露 定期报告 2022-10-18
2022-10-31 3938.11 未披露
更多>>
From July 31, 2021 to July 31, 2022 Common stock issued for employee stock purchase plan Stock-based compensation expense Common stock issued for services Exercise of common stock options
2022-07-31
2022-05-31 3936.55 未披露 定期报告 2022-05-18
2022-06-14 3936.44 未披露
更多>>
From January 31, 2022 to April 30, 2022 Stock-based compensation expense
2022-04-30
2022-03-15 3935.04 未披露 定期报告 2022-03-15
2022-03-15 3934.93 未披露
更多>>
From October 31, 2021 to January 31, 2022 Stock-based compensation expense Exercise of common stock options Common stock issued for employee stock purchase plan
2022-01-31
2021-12-15 3933.37 未披露 定期报告 2021-12-15
2021-12-15 3920.26 未披露
更多>>
From July 31, 2021 to October 31, 2021 Stock-based compensation expense Common stock issued for services
2021-10-31
2021-10-29 3915.26 未披露
更多>>
From July 31, 2020 to July 31, 2021 Common stock issued for employee stock purchase plan Exercise of common stock warrants Exercise of common stock options Stock-based compensation expense August 2020 Registered Direct Offering, net of $1,464,276 issuance costs January 2021 Public Offering, net of $2,970,165 issuance costs Purchase of shares under CGP and Sirtex stock purchase agreements Common stock issued for services
2021-07-31
2021-06-11 3918.53 未披露 定期报告 2021-06-11
2021-06-11 3887.15 未披露
更多>>
From January 31, 2021 To April 30, 2021 Exercise of common stock warrants Exercise of common stock options Stock-based compensation expense Purchase of shares under CGP and Sirtex stock purchase agreements Common stock issued for services
2021-04-30
2021-03-15 3715.97 未披露 定期报告 2021-03-12
2021-03-18 3714.72 未披露 定期报告 2021-03-09
2021-03-15 3649.20 未披露
更多>>
from October 31, 2020 to January 31, 2021 Common stock issued for employee stock purchase plan Exercise of common stock warrants Exercise of common stock options Stock-based compensation expense January 2021 Public Offering, net of $2,970,165 issuance costs Common stock issued for services
2021-01-31
2021-01-25 3540.59 未披露
更多>>
1.Common stock offered by the company 7,711,284 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 27,694,604 shares of common stock outstanding as of October 31, 2020.
2021-01-25
2020-12-11 2799.13 未披露 定期报告 2020-12-11
2020-11-30 2796.41 未披露 定期报告 2020-11-30
2020-12-11 2769.46 未披露
更多>>
From July 31, 2020 to October 31, 2020 Stock-based compensation expense August 2020 Registered Direct Offering, net of $1,464,276 issuance costs Common stock issued for services
2020-10-31
2020-10-28 2768.84 未披露 定期报告 2020-10-28
2020-08-19 2766.31 未披露
更多>>
1.Common stock offered by the company 4,608,589 shares of common stock, par value $0.0001 per share. 2.The number of shares of common stock to be outstanding after this offering is based on 22,771,571 shares of common stock outstanding as of April 30, 2020.
2020-08-19
2020-10-28 2305.45 未披露
更多>>
From July 31, 2019 to July 31, 2020 Common stock issued for employee stock purchase plan Stock-based compensation expense February 2020 Financing, net of issuance costs of$1,954,678 Common stock issued for services
2020-07-31
2020-06-15 2303.19 未披露 定期报告 2020-06-12
2020-06-15 2277.16 未披露
更多>>
From January 31, 2020 to April 30, 2020 Stock-based compensation expense Private placement in February 2020, net of issuance costs of $1,954,678 Common stock issued for services
2020-04-30
2020-03-16 2275.28 未披露 定期报告 2020-03-13
2020-03-16 1075.25 未披露
更多>>
from October 31, 2019 to January 31, 2020 Common stock issued for employee stock purchase plan Stock-based compensation expense Common stock issued for services
2020-01-31
2019-12-13 1071.07 未披露 定期报告 2019-12-13
2019-11-27 1069.54 未披露 定期报告 2019-11-18
2019-12-13 1068.04 未披露
更多>>
from July 31, 2019 to October 31, 2019 Stock-based compensation expense Common stock issued for services
2019-10-31
2019-10-28 1067.29 未披露 定期报告 2019-10-25
2019-08-23 1063.71 未披露 定期报告 2019-08-21
2019-10-28 1063.30 未披露
更多>>
from July 31, 2018 to July 31, 2019 Repurchase of fractional shares Exercise of common stock options Common stock issued for employee stock purchase plan Stock-based compensation expense Private placement on October 8, 2018, net of issuance costs of $573,189 Private placement on December 6, 2018, net of issuance costs of $304,916 Private placement on May 24, 2019, net of issuance costs of $1,025,655 Private placement, net of issuance costs of $80,575 Modification of equity award Common stock issued for services
2019-07-31
2019-06-14 1061.67 未披露 定期报告 2019-06-14
2019-05-30 1047.51 未披露 定期报告 2019-05-22
2019-06-14 711.13 未披露
更多>>
from January 31, 2019 to May 21, 2019 Stock-based compensation expense Private placement, net of issuance costs of $80,575 Common stock issued for services As a result of the reverse stock split, every 10 shares of common stock issued and outstanding were consolidated into one issued and outstanding share. The reverse stock split reduced the Company's issued and outstanding shares of common stock from approximately 70 million to approximately 7 million. In addition, proportionate adjustments will be made to the exercise prices of the Company's outstanding stock options and warrants and to the number of shares issued and issuable under the Company's existing stock incentive plans.
2019-05-21
2019-03-08 6479.38 未披露 定期报告 2019-03-08
2019-03-08 6462.14 未披露 定期报告 2019-01-31
2018-12-14 6450.70 未披露 定期报告 2018-12-14
2018-12-14 5967.45 未披露 定期报告 2018-10-31
2018-10-19 5921.39 未披露 定期报告 2018-10-19
2018-10-19 5351.16 未披露
更多>>
from July 31, 2017 to July 31, 2018 Exercise of common stock warrants Exercise of common stock options Common stock issued for employee stock purchase plan Stock-based compensation expense At-the-market offering program, net of issuance costs of $299,963 Public offering on October 25, 2017, net of issuance costs of $901,137 Public offering in February 2018, net of issuance costs of $2,249,169 Common stock issued for services
2018-07-31
2018-06-13 5234.46 未披露 定期报告 2018-06-06
2018-06-13 5189.27 未披露 定期报告 2018-04-30
2018-03-09 5148.22 未披露 定期报告 2018-03-07
2018-03-09 3582.79 未披露 定期报告 2018-01-31
2017-12-07 3551.77 未披露 定期报告 2017-12-05
2017-11-28 3541.77 未披露 定期报告 2017-11-27
2017-11-28 3536.77 未披露 定期报告 2017-11-15
2017-12-07 2960.81 未披露
更多>>
from July 31, 2017 to October 31, 2017 Net loss Stock-based compensation Common stock issued for services Issuance of common stock through employee stock purchase plan Equity offerings , net of costs Accumulated other comprehensive income (loss) Exercise of common stock warrants (net)
2017-10-31
2017-10-25 2209.98 未披露 定期报告 2017-10-10
2017-10-25 2161.82 未披露
更多>>
from July 31, 2016 to July 31, 2017 Exercise of common stock warrants Exercise of common stock options Common stock issued for employee stock purchase plan
2017-07-31
2017-06-01 2116.82 未披露 定期报告 2017-04-30
2017-03-16 2086.82 未披露 定期报告 2017-03-13
2016-12-08 1973.46 未披露 定期报告 2016-12-01
2016-12-08 1958.46 未披露 定期报告 2016-10-31
2016-10-13 1915.96 未披露 定期报告 2016-10-07
2016-08-23 1870.41 未披露 定期报告 2016-08-22
2016-10-13 1803.63 未披露
更多>>
From July 31, 2015 to July 31, 2016 Exercise of common stock warrants Common stock issued for services Public offering on November 9, 2015, net of issuance costs of $613,915 Public offering on May 26, 2016, net of issuance costs of $767,700 On November 3, 2015, the Company entered into a Securities Purchase with certain accredited investors pursuant to which the Company has agreed to issue and sell to the Purchasers in a registered public offering an aggregate of 2,142,860 shares of the Company’s Common Stock and warrants to purchase an aggregate of 1,071,430 shares of the Company’s Common Stock at a purchase price of $3.50 per unit, for aggregate expected gross proceeds of approximately $7.5 million.
2016-07-31
2016-06-09 1763.63 未披露 定期报告 2016-06-01
2015-12-08 1697.12 未披露
更多>>
On November 3, 2015, the Company entered into a Securities Purchase with certain accredited investors pursuant to which the Company has agreed to issue and sell to the Purchasers in a registered public offering an aggregate of 2,142,860 shares of the Company’s Common Stock and warrants to purchase an aggregate of 1,071,430 shares of the Company’s Common Stock at a purchase price of $3.50 per unit, for aggregate expected gross proceeds of approximately $7.5 million.
2015-12-01
2015-10-21 1482.84 未披露 定期报告 2015-10-07
2015-10-14 1482.09 未披露
更多>>
from July 31, 2014 to July 31, 2015 Exercise of common stock warrants Exercise of common stock options Common stock issued for services Public offering on June 9, 2015, net of issuance costs of approximately $1,091,794 Effective May 18, 2015, the Company implemented a reverse stock split pursuant to which each 20 shares of issued and outstanding common stock held by each stockholder were combined into and became one share of common stock, with such resulting shares rounded up to the next whole share.
2015-07-31
2015-05-26 1235.01 未披露 定期报告 2015-05-26
2015-06-09 1235.18 未披露
更多>>
Effective May 18, 2015 and pursuant to the reverse stock split approved by our Board of Directors, each 20 shares of issued and outstanding common stock and warrants, respectively, were combined into and became one share of common stock and no fractional shares were issued.
2015-05-19
2015-03-12 24700.23 未披露 定期报告 2015-03-06
2015-03-12 24692.73 未披露 定期报告 2015-01-31
Common Stock offered 1,408,384 shares by the company
Common Stock offered 1,582,932 shares by the company
From October 31, 2022 to January 31, 2023 Stock-based compensation expense December 2022 Public Offering, net of $680,181 issuance costs Exercise of pre-funded warrants Reverse split fractional shares Common stock issued for employee stock purchase plan
Common Stock offered 1,166,667 shares by the company
OncoSec Medical Incorporated announced it intends to effect a 1-for-22 reverse split of its issued and outstanding common stock. The reverse stock split will become effective on November 9, 2022.
From July 31, 2021 to July 31, 2022 Common stock issued for employee stock purchase plan Stock-based compensation expense Common stock issued for services Exercise of common stock options
From January 31, 2022 to April 30, 2022 Stock-based compensation expense
From October 31, 2021 to January 31, 2022 Stock-based compensation expense Exercise of common stock options Common stock issued for employee stock purchase plan
From July 31, 2021 to October 31, 2021 Stock-based compensation expense Common stock issued for services
From July 31, 2020 to July 31, 2021 Common stock issued for employee stock purchase plan Exercise of common stock warrants Exercise of common stock options Stock-based compensation expense August 2020 Registered Direct Offering, net of $1,464,276 issuance costs January 2021 Public Offering, net of $2,970,165 issuance costs Purchase of shares under CGP and Sirtex stock purchase agreements Common stock issued for services
From January 31, 2021 To April 30, 2021 Exercise of common stock warrants Exercise of common stock options Stock-based compensation expense Purchase of shares under CGP and Sirtex stock purchase agreements Common stock issued for services
from October 31, 2020 to January 31, 2021 Common stock issued for employee stock purchase plan Exercise of common stock warrants Exercise of common stock options Stock-based compensation expense January 2021 Public Offering, net of $2,970,165 issuance costs Common stock issued for services
1.Common stock offered by the company 7,711,284 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 27,694,604 shares of common stock outstanding as of October 31, 2020.
From July 31, 2020 to October 31, 2020 Stock-based compensation expense August 2020 Registered Direct Offering, net of $1,464,276 issuance costs Common stock issued for services
1.Common stock offered by the company 4,608,589 shares of common stock, par value $0.0001 per share. 2.The number of shares of common stock to be outstanding after this offering is based on 22,771,571 shares of common stock outstanding as of April 30, 2020.
From July 31, 2019 to July 31, 2020 Common stock issued for employee stock purchase plan Stock-based compensation expense February 2020 Financing, net of issuance costs of$1,954,678 Common stock issued for services
From January 31, 2020 to April 30, 2020 Stock-based compensation expense Private placement in February 2020, net of issuance costs of $1,954,678 Common stock issued for services
from October 31, 2019 to January 31, 2020 Common stock issued for employee stock purchase plan Stock-based compensation expense Common stock issued for services
from July 31, 2019 to October 31, 2019 Stock-based compensation expense Common stock issued for services
from July 31, 2018 to July 31, 2019 Repurchase of fractional shares Exercise of common stock options Common stock issued for employee stock purchase plan Stock-based compensation expense Private placement on October 8, 2018, net of issuance costs of $573,189 Private placement on December 6, 2018, net of issuance costs of $304,916 Private placement on May 24, 2019, net of issuance costs of $1,025,655 Private placement, net of issuance costs of $80,575 Modification of equity award Common stock issued for services
from January 31, 2019 to May 21, 2019 Stock-based compensation expense Private placement, net of issuance costs of $80,575 Common stock issued for services As a result of the reverse stock split, every 10 shares of common stock issued and outstanding were consolidated into one issued and outstanding share. The reverse stock split reduced the Company's issued and outstanding shares of common stock from approximately 70 million to approximately 7 million. In addition, proportionate adjustments will be made to the exercise prices of the Company's outstanding stock options and warrants and to the number of shares issued and issuable under the Company's existing stock incentive plans.
from July 31, 2017 to July 31, 2018 Exercise of common stock warrants Exercise of common stock options Common stock issued for employee stock purchase plan Stock-based compensation expense At-the-market offering program, net of issuance costs of $299,963 Public offering on October 25, 2017, net of issuance costs of $901,137 Public offering in February 2018, net of issuance costs of $2,249,169 Common stock issued for services
from July 31, 2017 to October 31, 2017 Net loss Stock-based compensation Common stock issued for services Issuance of common stock through employee stock purchase plan Equity offerings , net of costs Accumulated other comprehensive income (loss) Exercise of common stock warrants (net)
from July 31, 2016 to July 31, 2017 Exercise of common stock warrants Exercise of common stock options Common stock issued for employee stock purchase plan
From July 31, 2015 to July 31, 2016 Exercise of common stock warrants Common stock issued for services Public offering on November 9, 2015, net of issuance costs of $613,915 Public offering on May 26, 2016, net of issuance costs of $767,700 On November 3, 2015, the Company entered into a Securities Purchase with certain accredited investors pursuant to which the Company has agreed to issue and sell to the Purchasers in a registered public offering an aggregate of 2,142,860 shares of the Company’s Common Stock and warrants to purchase an aggregate of 1,071,430 shares of the Company’s Common Stock at a purchase price of $3.50 per unit, for aggregate expected gross proceeds of approximately $7.5 million.
On November 3, 2015, the Company entered into a Securities Purchase with certain accredited investors pursuant to which the Company has agreed to issue and sell to the Purchasers in a registered public offering an aggregate of 2,142,860 shares of the Company’s Common Stock and warrants to purchase an aggregate of 1,071,430 shares of the Company’s Common Stock at a purchase price of $3.50 per unit, for aggregate expected gross proceeds of approximately $7.5 million.
from July 31, 2014 to July 31, 2015 Exercise of common stock warrants Exercise of common stock options Common stock issued for services Public offering on June 9, 2015, net of issuance costs of approximately $1,091,794 Effective May 18, 2015, the Company implemented a reverse stock split pursuant to which each 20 shares of issued and outstanding common stock held by each stockholder were combined into and became one share of common stock, with such resulting shares rounded up to the next whole share.
Effective May 18, 2015 and pursuant to the reverse stock split approved by our Board of Directors, each 20 shares of issued and outstanding common stock and warrants, respectively, were combined into and became one share of common stock and no fractional shares were issued.
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。